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Circulating cell-free DNA, telomere 
length and bilirubin in the Vienna 
Active Ageing Study: exploratory 
analysis of a randomized, 
controlled trial
Anela Tosevska1, Bernhard Franzke1, Marlene Hofmann2, Immina Vierheilig3, 
Barbara Schober-Halper1, Stefan Oesen1, Oliver Neubauer1,4, Barbara Wessner1,2 
& Karl-Heinz Wagner1,3
Telomere length (TL) in blood cells is widely used in human studies as a molecular marker of ageing. 
Circulating cell-free DNA (cfDNA) as well as unconjugated bilirubin (UCB) are dynamic blood 
constituents whose involvement in age-associated diseases is largely unexplored. To our knowledge, 
there are no published studies integrating all three parameters, especially in individuals of advanced 
age. Here we present a secondary analysis from the Vienna Active Aging Study (VAAS), a randomized 
controlled intervention trial in institutionalized elderly individuals (n = 101). Using an exploratory 
approach we combine three blood-based molecular markers (TL, UCB and cfDNA) with a range of 
primary and secondary outcomes from the intervention. We further look at the changes occurring in 
these parameters after 6-month resistance exercise training with or without supplementation.  
A correlation between UCB and TL was evident at baseline (p < 0.05), and both were associated with 
increased chromosomal anomalies such as nucleoplasmatic bridges and nuclear buds (p < 0.05). Of the 
three main markers explored in this paper, only cfDNA decreased significantly (p < 0.05) after 6-month 
training and dietary intervention. No clear relationship could be established between cfDNA and either 
UCB or TL. The trial was registered at ClinicalTrials.gov (NCT01775111).
Ageing is accompanied by an accumulation of macromolecular damage, leading to cellular dysfunction and ulti-
mately, tissue and organ malfunction1. In humans the ageing process appears to be a mixture of stochastic events 
leading to a high variability of phenotypical outcomes between individuals of the same age.
Telomere length is one of the most commonly used markers of ageing2. Telomere shortening is a result of the 
mitotic activity of a cell, and in humans it roughly corresponds to the age of the organism3. On the other hand, 
telomere length has a limited power as an age biomarker due to a very high inter-individual variation4,5. While a 
clear decline is visible when comparing healthy individuals throughout a broad age range, this difference is often 
negligible over a more narrow range. This is especially the case when comparing individuals at a more advanced 
age, when telomeres appear to shorten at a reduced rate6. Moreover, studies in humans often use blood cells as 
a test material for measuring telomere length7,8. As blood cells comprise a mixture of different individual cell 
types with different mitotic history, telomere length measured in these samples can additionally show a large 
intra-individual variability7,9. Therefore, there is an increased need for identifying reliable and clinically accessible 
molecular markers of ageing, which would complement telomere length as a marker10.
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It has been previously shown11–13 that chromosomal abnormalities arise more frequently in the elderly pop-
ulation. The increased chromosomal instability, in absence of malignancy, will ultimately lead to increase in cell 
death. Dying and dead cells release their content extracellularly, and a portion of the genomic DNA can be found 
circulating in the bloodstream before final excretion as a waste product14. A recent review15 suggests the possi-
bility of cell-free genomic-derived DNA (cfDNA) integration into the genome of living cells, leading further to 
increased genome instability.
Breitbach et al.16 proposed that this circulating cfDNA can be additionally excreted in an active manner from 
living cells and could play a role in cell signalling. Circulating concentrations of cfDNA have been shown to 
increase rapidly after strenuous exercise, and return to normal within hours or days16. However, much of the 
physiological and pathophysiological relevance of cfDNA remains unknown, so far.
Jylhava et al.17–19 have investigated cfDNA as a possible ageing biomarker in healthy individuals. In a 
genome-wide association study (GWAS) a potential involvement of the UDP-glucuronosyltransferase UGT1A1 
in the excretion of cfDNA was revealed20. This enzyme is highly specific for metabolising unconjugated bilirubin 
(UCB) into water-soluble products that can be easily excreted from the organism21. However, there is no pub-
lished data looking at a potential relationship or interaction between UCB and cfDNA in humans.
Unconjugated bilirubin has been suggested to play an important role in human disease prevention, especially 
in relation to age-associated diseases22. A number of epidemiological studies have found an inverse relationship 
between increased serum bilirubin and age-associated disease incidence23–25. We have recently identified a rela-
tionship between mildly increased UCB, characteristic for a condition called Gilbert’s Syndrome, and telomere 
length26. These individuals present with serum bilirubin levels above 17.1 umol/L whereas non-affected individu-
als range between 3 and 17.1 umol/L. There are indications that even in non-Gilbert’s Syndrome individuals con-
centrations higher than 10 umol/L can be indicative for a reduced disease risk23. However, it is not clear whether 
this intermediately increased UCB concentration is linked to longer telomeres in non-affected individuals.
The Vienna Active Ageing Study (VAAS) has been investigating different aspects of the ageing process in insti-
tutionalized elderly individuals, and the effects of resistance training and nutritional supplementation interven-
tion on overall fitness and health-related parameters. Published data on this study have shown an improvement 
in physical performance in individuals undergoing an exercise training intervention, compared to sedentary 
controls27, as well as a trend for a decreased chromosomal and DNA damage in the entire study population28. 
The main aim of this paper was to investigate a potential relationship between blood telomere length, cfDNA and 
unconjugated bilirubin at baseline and after a 6-month training intervention. We further conducted an explora-
tory analysis in order to identify relationships between cfDNA, UCB and TL on one side and chromosomal dam-
age endpoints, physical performance measures, CVD markers and oxidative damage end products on the other. 
Based on previous knowledge we hypothesized that there is an inverse relationship between TL and UCB on one 
side, and cfDNA and markers of chromosomal instability on the other.
Results
Baseline characteristics of the entire cohort. The baseline study characteristics have been described 
elsewhere11. From the 105 individuals that complied to the initially established inclusion criteria15,27, we addition-
ally excluded 4 individuals with increased reference values of liver enzymes (ALT, AST or GGT). Increased liver 
enzymes were important indicators for liver abnormality which might influence bilirubin levels, a key variable in 
this analysis. As the percentage of males in this study population was too low to achieve statistical relevance, we 
carried out all further analyses on a pooled population of both genders. Supplementary Figure S1 shows that no 
clear distinction and clustering can be seen between males and females using a Principal Component Analysis 
(PCA).
Five individuals fitted the criterion for Gilbert’s Syndrome (UCB concentration ≥ 17.1 µ M), corresponding to 
an incidence of about 5% in our study population. This goes in line with the estimated incidence of this condition 
in the general population29. PCA analyses showed that these individuals cluster close together, but are not distinct 
from the rest of the participants in this study cohort (Supplementary Figure S2).
Correlations at baseline. We used Pearson and Spearman correlation matrices (Fig. 1) to explore colline-
arity between variables and baseline. As most variables were non-parametric (Supplementary Figure S3.) we only 
considered Spearman statistics (Supplementary Table S1). Pearson correlation matrix is shown only as a descrip-
tive. We summarize only the most important observations.
Age had no effect on cfDNA levels in the study population at baseline. Additionally, we could not detect any 
relationship between age and telomere length. UCB, on the other hand, showed a monotonic increase with age in 
our study sample (ρ = 0.23, p = 0.025).
Although baseline UCB showed a moderate positive Pearson correlation with cfDNA (r = 0.257), Spearman 
statistics showed no significance. In contrast, telomere length and UCB showed a significant correlation at base-
line (ρ = 0.238, p = 0.047). In addition, a relationship of UCB with blood haemoglobin was observed (ρ = 0.26, 
p = 0.012).
Both UCB and telomere length at baseline correlated positively with the number of nucleoplasmatic bridges 
(NPBs) (ρ = 0.21, p = 0.043 and ρ = 0.41, p = 0.001, respectively) and nuclear buds (NBuds) (ρ = 0.24, p = 0.019 
and ρ = 0.51, p = 0.004). On the contrary, MDA showed an inverse correlation with both NPBs and NBuds 
(ρ = − 0.32, p = 0.001 and ρ = − 0.34, p < 0.001), but not with TL or UCB. Whole blood telomere length and uri-
nary levels of oxidized guanine showed a negative Pearson correlation (r = − 0.34) which was not significant using 
Spearman statistics. There were no significant correlations between TL and cfDNA and any physical performance 
parameters such as chair rise test or 6-minutes walking test.
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Six-months-finishers at baseline.  The study participants were randomly assigned to three intervention 
groups: resistance exercise training (RT), resistance training and supplementation (RTS), and a control group 
(CT) undergoing a cognitive intervention only. Table 1 shows the baseline characteristics of the 6-months finish-
ers, divided by intervention groups.
Changes after six months exercise training. Cell-free DNA concentrations were reduced significantly 
after 6 months RTS intervention (t-statistics = 2.92, p-value = 0.008), but not in the CT or RT-only groups. There 
Figure 1. Pearson and Spearman correlation matrices at baseline. Values of Pearson r or Spearman ρ 
coefficients are given in the correspondent glyph. Pearson correlation matrix (left panel); Spearman correlation 
matrix (right panel). The glyphs are marked with colour only if they show a correlation at P < 0.05 level. Blue 
colour represents positive correlation whereas red represents negative correlation. Numerical p-values are 
shown in Supplementary Table S1. Abbreviations and units are given in the supplementary material.
RT (n = 23–30) RTS (n = 21–23) CT (n = 20–26) Total (n = 64–79)
Age (years) 82 ± 6 81 ± 8 84 ± 5 83 ± 6
BMI (kg/m2) 28.97 ± 3.86 29.41 ± 5.31 27.94 ± 5.12 28.76 ± 4.72
NDI 1.95 ± 0.08 1.98 ± 0.06 1.98 ± 0.07 1.97 ± 0.07
MNi frequency/1000 BN cells 28.60 ± 15.60 28.17 ± 18.43 23.70 ± 9.53 26.90 ± 14.90
NPBs/1000 BN cells 1.17 ± 1.21 0.93 ± 0.88 1.36 ± 1.03 1.16 ± 1.06
NBuds/1000 BN cells 3.47 ± 2.67 3.35 ± 2.46 4.42 ± 4.85 3.74 ± 3.46
Stand-up Test (repetitions) 12.31 ± 3.07 13.77 ± 4.28 12.13 ± 4.44 12.68 ± 3.92
6 min Walking Test (m) 384 ± 79 373 ± 99 382 ± 97 380 ± 90
Body Fat (%) 33.87 ± 7.36 33.89 ± 9.14 32.59 ± 9.69 33.48 ± 8.55
Glucose (mg/dl) 108 ± 25 99 ± 11 107 ± 22 105 ± 21
hs-Insulin (µ IU/ml) 9.77 ± 6.91 10.43 ± 6.33 8.60 ± 7.74 9.58 ± 6.98
Cholesterol (mg/dl) 205 ± 41 209 ± 37 205 ± 38 206 ± 38
HDL (mg/dl) 62.57 ± 14.03 66.74 ± 17.88 63.69 ± 20.09 64.15 ± 17.20
LDL (mg/dl) 120 ± 37 119 ± 39 118 ± 32 119 ± 35
Chol/HDL Ratio (%) 3.40 ± 0.86 3.33 ± 1.01 3.45 ± 0.95 3.40 ± 0.92
Triglycerides (mg/dl) 113 ± 38 118 ± 45 114 ± 47 115 ± 43
Lipoprotein A1 (mg/dl) 16.22 ± 19.66 36.85 ± 50.70 26.42 ± 37.69 25.58 ± 37.35
hs-CRP (mg/l) 6.50 ± 13.27 5.66 ± 9.08 3.96 ± 4.02 5.42 ± 9.75
UCB (µ mol/l) 8.75 ± 5.68* 6.15 ± 3.33 6.35 ± 2.13 7.16 ± 4.20
hsTroponin-T (ng/ml) 0.01 ± 0.01 0.01 ± 0.01 0.02 ± 0.02 0.01 ± 0.02
NT-pro BNP (pg/ml) 393 ± 779 280 ± 370 467 ± 672 385 ± 644
cfDNA (ng/ml) 185 ± 47 197 ± 55 185 ± 62 188 ± 54
MDA (µ mol/l) 1.97 ± 0.42 1.89 ± 0.44 1.89 ± 0.36 1.92 ± 0.41
Telomere Length (kb) 2.92 ± 1.16 2.76 ± 1.63 3.05 ± 0.94 2.91 ± 1.27
Table 1.  Baseline Characteristics of 6-months finishers divided by intervention group. Values are 
represented as mean ± standard deviation. Differences between intervention groups are marked with *for 
P-value < 0.05, **for P-value < 0.01 and #for trend (P < 0.1). One way ANOVA.
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was no significant difference in telomere length or UCB concentrations in any of the intervention groups after 6 
months, as shown is Fig. 2.
We consecutively determined whether the baseline concentrations of our key variables correlated with the 
change in the same parameter after 6 months intervention. The 6-month change in telomere length correlated 
inversely with telomere length at baseline in the entire cohort and all intervention groups separately (p < 0.001, 
Fig. 3a). The same was observed for cfDNA concentrations in the entire cohort (p < 0.001, Fig. 3b), even though 
the correlation did not reach significance in the RT group. UCB concentrations at baseline had no influence on 
the observed 6-month change in any of the intervention groups (Fig. 3c).
Figure 2. Paired-differences between pre-and post-intervention values for the main parameters. Each 
orange dot represent a value pre-intervention and green dots are 6-months post-intervention. Bold black line 
represents the average change. Only cell-free DNA in the RTS group exhibited a significant decrease (p = 0.009, 
paired t-test). Control group, number of pairs included: cfDNA, n = 23; TL, n = 20; UCB, n = 16. Training 
group, number of pairs included: cfDNA, n = 27; TL, n = 18; UCB, n = 18. Training and supplementation group, 
number of pairs included: cfDNA, n = 20; TL, n = 18; UCB, n = 11.
www.nature.com/scientificreports/
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Correlations after six months exercise training. We next aimed to investigate which parameters exhibit 
a similar pattern with regards to negative or positive change after 6 months intervention, using a Spearman corre-
lation matrix. The correlation matrices stratified by intervention groups are depicted in Fig. 4. We briefly describe 
the most relevant correlations.
Changes in telomere length and cfDNA did not correlate to each other in any of the intervention groups. An 
increase in cfDNA was associated with decreased chair rise repetitions in the CT and RTS groups, whereas a 
deterioration of the 6 min walking test was accompanied by an increase in cfDNA in the RT group only. Longer 
telomeres were associated with an improvement in the chair rise test in the RTS group but with a decrease in the 
TS group (ρ = 0.65, p = 0.005 and ρ = − 0.64, p = 0.01).
An increase in UCB in the CT group correlated strongly with the increase in blood hemoglobin (ρ = 0.73, 
p = 0.002). In the RT group, UCB concentration increase correlated with an increase in both NPBs (ρ = 0.59, 
p = 0.02) and NBuds (ρ = 0.59, p = 0.019). In the same group telomere length shortening was accompanied by an 
increase in intracellular chromosomal damage, such as formation of NBuds (ρ = 0.52, p = 0.037) and a decrease 
in nuclear division index (ρ = − 0.64, p = 0.007).
Figure 3. Scatter plot depicting correlations in the main variables at baseline to the respective 6-month 
change: (a) entire study population (TL, p < 0.001; UCB, non-significant; cfDNA, p < 0.001). (b) Divided 
by intervention group (TL: RT and RTS group: p < 0.001, CT group: p = 0.011; UCB: no group reached 
significance; cfDNA: RT group n.s., RTS: p = 0.025, CT: p = 0.012).
www.nature.com/scientificreports/
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A positive correlation between the observed changes in UCB and cfDNA was evident in the RT group only 
(r = 0.538, p = 0.032). An increase in UCB was correlated with an increase in DNA damage parameters, especially 
NPBs, in both training groups (RT group: r = − 0.576, p = 0.024; RTS group: r = − 0.611, p = 0.060).
Discussion
The present study investigated the relationship between circulating cell-free DNA, serum unconjugated bilirubin 
and telomere length in a predominantly female elderly population. To our knowledge, this is the first study inves-
tigating the interplay between these parameters within elderly individuals. Moreover, the novelty of these data is 
in linking these markers in response to a prolonged intervention involving exercise training with and without a 
dietary supplementation.
Telomere length and circulating cell-free DNA at baseline were not affected by age in this study population. 
The possible reason for this finding is the advanced age of the study participants leading to a relatively broad 
variance in most baseline parameters. All study participants were between 65 and 98 years of age, where the dis-
crepancy between biological and chronological age is the greatest. Additionally, it is very plausible that individuals 
that have reached a more advanced age in good health have a more favourable molecular ageing pattern than their 
slightly younger peers30.
We hypothesized that telomere length at baseline would be inversely associated with markers of chromosomal 
instability and oxidative DNA damage. In contrast, we expected cell-free DNA to increase with the levels of chro-
mosomal damage. Contrary to our hypothesis, longer telomeres were associated with increased chromosomal 
instability at baseline, measured by an increase in nucleoplasmatic bridges (NPBs) and nuclear buds (NBuds). 
Nucleoplasmatic bridges are formed as a result of erroneous DNA repair and telomere fusion of two chromo-
somes13. This process is triggered by critical telomere shortening and uncapping. However, to our knowledge, 
there is no indication that NPBs formation can lead to telomere elongation. Some evidence suggests that in a case 
of folate deprivation NBuds might contain a larger amount of telomeric DNA, leading to an abnormal increase in 
telomeric content31. The present study participants indeed had an inadequate baseline level of folate28 in erythro-
cytes, which might partly explain our results.
Baseline concentrations of cfDNA did not reflect the extent of DNA or chromosomal damage in PBMCs 
occurring simultaneously, measured by the CBMN assay end-points such as micronuclei frequencies, NPBs and 
NBuds formation. Notably, cfDNA levels in plasma did not appear abnormally high for any of the study partici-
pants. For cfDNA integration into healthy cells16, it is likely that much higher levels of cfDNA would be required.
There was a weak positive correlation between telomere length and UCB at baseline. This is in agreement 
with our recent results suggesting an occurrence of longer telomeres in individuals with Gilbert’s Syndrome, a 
condition of mild chronic hyperbilirubinaemia26. Approximately 5% of our study population matched the crite-
rion for GS diagnosis, showing increased UCB levels over the diagnostic minimum for GS. Interestingly none of 
the potential GS showed a tendency for short telomeres (Supplementary Figure 4a). However, it this setting, the 
group size was too small to make a statistically sound conclusion. It should be taken in consideration that the 
present study was conducted using a different starting material for DNA extraction (i.e. whole blood instead of 
isolated PBMCs) which excludes the possibility for direct comparison between the studies.
The relationship between UCB levels and cfDNA appears to be more complex. Even though there was no 
direct significant relationship between the two, the levels of cfDNA were consistently higher in individuals sus-
pected for GS. These individuals have distinctly higher UCB levels and appear as outliers to the entire group 
(Supplementary Figure 4b). As we have no information on the UGT1A1 genotype of participants in the present 
study, we could only assume that the ones showing an increased UCB concentration indeed carry a mutation in 
Figure 4. Spearman correlation matrices describing relationships between changes after 6-month 
intervention training, stratified by intervention group. Values of Spearman ρ coefficients are given in the 
correspondent glyph. The glyphs are marked with colour only if they show a correlation at P < 0.05 level. Blue 
colour represents positive correlation whereas red represents negative correlation. Control group CT, n = 9–22 
(left panel); resistance training and supplementation group RTS n = 9–22 (middle); resistance training group 
RT, n = 10–29 (right panel). Numerical P-values are shown in Supplementary Table S2. Abbreviations and units 
are given in the supplementary material.
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their UGT1A1 gene which additionally slows down the excretion of circulating cfDNA entities. Another possi-
bility is that the free UCB fraction in plasma is binding to the free DNA fraction. A study has reported that bili-
rubin can bind DNA in presence of Cu(II)-ions, which could promote oxidative DNA damage32. However, more 
research is needed in order to get an insight if UCB and cfDNA are directly interacting, or are merely targets of 
the same metabolic pathway.
The main outcomes of the Vienna Active Ageing Study related to improvement in physical fitness parameters 
have been described earlier27. Briefly, functional parameters have been found to improve over time and related to 
the training intervention. In addition, chromosomal damage, such as micronuclei frequencies or NPBs showed 
a trend to decrease in all three groups28. The supplementation group acquired improvements in plasma vitamin 
B12 and folate status in erythrocytes28. While acute exercise increases the concentration of cfDNA within hours 
post-exercise, it is being quickly eliminated and returns to normal values within a few days16. However, the effect 
of regular moderate exercise on long-term cfDNA levels has not been reported so far. We observed a significant 
decrease in cfDNA levels in the RTS group after 6 months. There was no association between cfDNA and B12 or 
folate or the changes occurring in these parameters between the two time-points (data not shown). It is possi-
ble that there was an indirect effect of the latter two on the reduced cfDNA in plasma. As the role of circulating 
cfDNA is not yet well defined, we cannot exclude that the observed reduction in the training and supplementation 
group might not be beneficial at all as cfDNA could potentially play a role in the training adaptation.
Mean telomere length has not changed drastically throughout the course of 6 months. It has been shown 
previously that telomeres shorten at a rate of only about 30 bp/year which is difficult to detect with any standard 
telomere measurement method33. However, there have been reports7 of telomere length fluctuations with time in 
whole blood samples, which occurs due to a shift in cell populations throughout the intervention period. Similar 
to the observations from Svenson et al., there was an inverse correlation between telomere length measured at 
baseline and the 6-month change, independently from the training intervention. These intra-individual fluctua-
tions in blood telomere length should be considered carefully when using telomere length as a marker, which is 
its main limitation.
Similarly to the outcomes at baseline, the change in measured intracellular damage parameters in the training 
group is closely followed by a change in TL and UCB. Additionally, and contrary to our expectations, telomere 
shortening correlated with higher improvement in the chair rise test. It is unclear from our results if there is any 
causal relationship between these parameters.
Taken together, we have shown a relationship between telomere length, unconjugated bilirubin and chro-
mosomal anomalies in an elderly population, in the light of a lifestyle intervention. On the other hand, cfDNA 
showed no connections to any of the tested parameters. Perhaps, due to the very transient nature of cfDNA, a 
study dealing with acute outcomes would be more appropriate. Instead, we can emphasize the potential role of 
UCB as a key player in age-associated cellular signalling.
Materials and Methods
Subject recruitment and sample preparation. A total of 117 (of which blood samples were available 
from 105) institutionalized elderly individuals aged 65–98 years (both men and women) were recruited from 
five different senior residencies in Vienna, Austria (Curatorship of Viennese retirement homes)11,27. The subjects 
were mentally (Mini Mental State Examination ≥ 23) and physically (Short Physical Performance Battery > 4) 
able to participate in the study. Furthermore, they were sedentary (< 1 h of physical activity or exercise per week) 
and free of conditions contraindicated with medical training therapy or measurement of physical performance, 
such as cardiovascular diseases, diabetic retinopathy and regular use of cortisone-containing drugs. Regular 
strength training (> 1× /week) in the last 6 months before the study beginning was an exclusion criterion. Written 
informed consent was obtained from all participants before entry, and the study was performed in accordance 
with the Declaration of Helsinki. This study was approved by the ethics committee of the City of Vienna (EK-11-
151-0811) and registered at ClinicalTrials.gov (NCT01775111) on January 21st, 2013.
The study was conducted in a randomized, controlled, observer-blind design. The participants were randomly 
divided into three groups – cognitive training (CT), resistance training (RT), RT + protein supplement (RTS) – 
and matched for gender. Blood samples were taken and physical performance tests were executed before (T1 or 
pre), and after six months (T3 or post) of intervention.
Plasma values of liver enzymes (AST, ALT, GGT) elevated over 10% above the reference values was an addi-
tional exclusion criterion, as unconjugated bilirubin can be affected by altered liver function. This lead to exclu-
sion of additional 4 study participants.
Blood samples were collected early morning after an overnight fast using heparin, serum and EDTA tubes 
(Greiner Bio-One, Kremsmunster, Austria). Peripheral blood lymphocytes were isolated using Ficoll separation 
tubes (Greiner Bio-One).
Study intervention design. A detailed description on the training protocol, protein and micronutrient 
supplementation and cognitive training are given by Franzke et al.28. Briefly, the resistance training groups (RT 
and RTS) received two weekly sessions of resistance training, conducted on two non-consecutive days and super-
vised by a sport scientist. Exercises were conducted using elastic bands, chairs and own body weight27. In the 
initial phase (4 weeks) one set of 15 repetitions was performed in order to learn the correct form of each exercise. 
From the fifth week on the intensity and volume has progressively been increased from two sets of light exercises 
to two sets of heavy resistance. If the participants could easily perform two sets of 15 repetitions they were told to 
either take more resistance or to perform a more difficult version of the exercise.
The RTS group additionally received a nutritional supplement every morning, as well as directly after each 
training session. Each drink supplied a total energy of 150 kcal and contained 20.7 g protein (56 energy (En)%, 
19.7 g whey protein, 3.0 g leucine, > 10 g essential amino acids), 9.3 g carbohydrates (25 En%, 0.8 BE), 3.0 g fat 
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(18 En%), 1.2 g roughage (2 En%), 800IU (20 µ g) of vitamin D, 250 mg calcium, vitamins C, E, B6 and B12, folic 
acid and magnesium (FortiFit, NUTRICIA GmbH, Vienna, Austria).
The CT group performed coordinative or cognitive tasks two times per week, equally to the RT and RTS 
groups in order to avoid socialization bias. Participants of all groups were instructed to maintain their regular 
food intake.
Chair rise test. To perform well in the chair rise test, the participants had to stand up from a chair (46 cm 
seat height) as often as possible within 30 s. To ensure a safe test-setting, the chair was placed against the wall. For 
one successful repetition, participants had to fully stand up (hip and knee fully extended) and sit back, with their 
arms crossed over their chest. A last-second-attempt was considered valid, if the person had covered more than 
50% of the range of motion11,27.
Handgrip strength test. To assess handgrip strength, participants performed an isometric handgrip 
strength test (kg) using a dynamometer. The test was conducted in a sitting position and maximal isometric 
contraction within 4–5 s was measured (JAMAR compatible handgrip dynamometer adapted to handle different 
sizes). The better result of two trials (one minute break in between) for each hand was noted11,27.
Six minute walking test. The participants had to walk for 6 min as fast and as far as possible. The 6 minute 
walking test is a valid tool to evaluate aerobic endurance in the elderly. Participants were allowed to slow down 
and even take a short rest. Every subject performed the test separately without being disturbed by others. They 
had to walk back and forth on a 30 meter shuttle track and the distance covered within 6 min was registered11,27.
Circulating cell-free DNA measurement. Circulating cell-free DNA was measured from frozen EDTA 
plasma using a QuantiFluor® dsDNA System (Promega), as a plate-based assay. The plasma was thawed and cen-
trifuged for 1 min at 3000 rpm, to remove all insoluble debris. Samples were measured in triplicates, according to 
the manufacturer’s protocol. To exclude possible interferences from other plasma-derived molecules, each plasma 
sample was also run without addition of dsDNA dye and used as a blank for the corresponding sample.
Cytokinesis block micronucleus cytome assay. The cytokinesis block micronucleus cytome (CBMN) 
assay was performed according to a published protocol34. Cells were stimulated to undergo mitosis, using phyto-
haemagglutinin (PAA, Pasching, Austria) using a concentration of 1 × 106 cells/mL in culture medium. Samples 
were incubated at 37 °C and 5% CO2. After exactly 44 h, cytochalasin B (Sigma Aldrich, Vienna, Austria) was 
added to block cytokinesis. After exactly 72 h from the start of the experiment, cells were spotted onto microscope 
slides, stained (Diff-Qick; Medion Diagnostics, Dudingen, Switzerland) and counted using a bright field micro-
scope (1000-fold magnification; Olympus, Wien, Austria).
Each sample was run in duplicate and two slides of each replicate were produced. From the four resulting 
slides, 500 cells per slide (2000 per subject) were counted.
To assess chromosomal damage in blood lymphocytes, the frequency of MN, NPBs and NBuds per 2000 binu-
cleated (BN) cells was counted, as well as the number of apoptotic and necrotic cells. Furthermore, the nuclear 
division index (NDI) was calculated to measure cytostatic effects and the mitogenic response of lymphocytes.
DNA extraction from whole blood and concentration measurement. DNA was extracted from 
100 µ l fresh whole blood, using the DNeasy blood and tissue mini kit (Qiagen) according to the manufacturer’s 
instructions. Extracted DNA was stored at − 20 °C. A random subset of samples were measured using NanoDrop 
2000c spectrophotometer (Thermo Scientific) and a A260/280 ratio between 1.7 and 1.9 was considered satisfac-
tory. DNA integrity was estimated by agarose gel electrophoresis. DNA concentration for qPCR was measured 
using the QuantiFluor® dsDNA System (Promega), as a plate-based assay on a FLUOstar OPTIMA microplate 
reader (BMG Labtech).
Telomere length measurement by quantitative polimerase chain reaction (qPCR). Telomere 
length was measured as described35, with modifications. Shortly, SYBR Select Master Mix (Life Technologies) was 
used to amplify telomeric sequences and single copy gene (36b4). Primers were used at a final concentration of 
100 nM. Genomic DNA samples were diluted to a concentration of 2.5 ng/uL, and 2 uL were used in each reac-
tion (5 ng/reaction). 84-base oligonucleotide standards were diluted to a stock solution of 50 pg/uL. To generate 
a telomere standard curve, 10-fold serial dilutions of the stock solution were prepared. For the single-copy gene 
(SCG) standard curve, the stock solution was diluted to 0.5 ng/uL, and serial dilutions were prepared thereof. 
Further details on the standard curve linear ranges are given in the supplementary methods section. All samples 
and standards were run in triplicate. Assays were run on a QuantStudio™ 6 Flex Real-Time PCR System (Thermo 
Fisher), using a 384-well block. To account for the effect of inter-plate variability, repeated measures from the 
same sample were run on the same plate.
Analyses were performed at a manual threshold of 2.461 for both targets, with a qPCR efficiency ranging 
between 90–110%. Samples with a standard deviation exceeding 0.5 Ct were excluded from the analysis. Absolute 
telomere length was calculated as previously described35. The final results were presented as length in kb of indi-
vidual telomeres; calculated as telomeric sequence per diploid genome in kb, divided by 92 (number of individual 
telomeres in the diploid genome).
Unconjugated bilirubin measurement by high performance liquid chromatography (HPLC). 
Unconjugated bilirubin were measured from serum samples, as described previously12, using a high-performance 
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liquid chromatograph (Merck, Hitachi, LaChrom, Vienna, Austria) equipped with a photodiode array detector 
(PDA, Shimadzu,) and a Fortis C18 HPLC column (4.6 × 150 mm, 3 µ m) and a phenomenex C18 HPLC guard 
column (4.0 × 3.0 mm). An isocratic mobile phase consisting of 0.1 M n-dioctylamine in methanol/water (95:5; 
v/v) and glacial acetic acid was used. Unconjugated bilirubin IX alpha (Frontier Scientific Europe, Carnforth, 
Lancashire, UK) served as an external standard. Sample and standard preparation and analysis were performed 
as previously published12.
Biochemical parameters. High sensitive Troponin-T (hs TNT) and NP-were analyzed immediately after 
blood sampling at a routine laboratory (study lab GmbH, Vienna).
Oxidized nucleotides in urine. Urine samples were collected on the morning of blood samplings and 
stored at −20 °C until further analyses. 8-oxo-7.8-dihydro-2′ -deoxyguanosine (8oxodG) was measured using 
an ultra-performance LC and MS/MS36. The results were normalized to urinary creatinine concentration deter-
mined by the Jaffe reaction.
Malondialdehyde (MDA). MDA levels were measured in plasma as described earlier37. Shortly, after heat-
ing (60 min, 100 °C) plasma samples were neutralized with methanol/NaOH, centrifuged (3 min, 3000 rpm) 
and MDA was measured using HPLC (excitation: λ = 532 nm, emission: λ = 563 nm, LaChrom Merck Hitachi 
Chromatography System, Vienna, Austria; HPLC column 125 × 4 mm, 5 µ m; Merck, Vienna, Austria).
Statistical analysis. The sample size calculation was based on a prerequisite alpha level set at 0.05 and a 
power of > 0.85 using G *Power3.1.038 which estimated the sample size to be 86 using isokinetic peak torque (con-
centric knee extension at an angular velocity of 60°/s.; range of motion 20°–80°) as primary endpoint. Previous 
studies in a similarly difficult collective show a high drop-out rate of about 35–40%. Therefore, a total of about 120 
subjects were included in the study27, of which 101 were included in the present analyses at baseline.
For the baseline bivariate correlations we used Pearson and Spearman statistics to test for linear or monotonic 
relationship. To test for differences between pre- and post-intervention within the same group we used a paired 
T-test or Wilcoxon signed-rank test. Baseline differences between intervention groups were determined using a 
one way ANOVA and a Bonferonni correction.
Values from 6-months finishers were paired as pre- and post- intervention and divided by intervention 
groups. We used a pairwise exclusion. For each group the z-scores were calculated as x − µ 0/σ 0, where x is the 
value, µ 0 is the group average at baseline and σ 0 the group standard deviation at baseline. This approach corrects 
for any inter-group baseline differences. The 6-months difference was calculated from the z-scores for each pair 
of pre- and post-intervention value.
All analyses were performed using R 3.2.4. or the scipy and numpy39 packages for Python 2.7.3. Scatter plots 
were generated using the matplotlib package for Python 2.7.340, the correlation matrices were generated using the 
corrplot package for R and the paired line plots using the ggplot241 package for R. PCA and the corresponding 
figures in supplementary material were generated using the COVAIN toolbox for Matlab42.
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